The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find... View more

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.View less

Pharmaceutical Published Insights

Coherent Market Insights Global Ear Health Market

Published Date : Aug 2024

Rising prevalence of ear conditions including otitis media and Meniere's disease, growing geriatric population susceptible to age-related ear issues, and increasing awareness regarding ear health can drive the market growth during the forecast period. Furthermore, tec... View more

Coherent Market Insights Orthokeratology Market

Published Date : Aug 2024

Orthokeratology is an established reversible non-surgical procedure that uses medical devices called contact lenses to temporarily reshape the curvature of the cornea. By wearing specially-designed contact lenses overnight, orthokeratology reshapes the cornea just eno... View more

Coherent Market Insights Alzheimers Drugs Market

Published Date : Aug 2024

Alzheimer's disease is a progressive neurodegenerative disease that slowly destroys memory and cognitive skills. It is the most common cause of dementia among older people. Global Alzheimer's drugs market growth is driven by rising prevalence of Alzheimer's disease wo... View more

Coherent Market Insights Us Cannabis Testing Service Market

Published Date : Aug 2024

US cannabis testing services market growth is driven by legalization of medical and recreational marijuana in several states. As more states move to regulate the cannabis industry, stringent quality control and product safety testing has become imperative. Cannabis te... View more

Coherent Market Insights Over The Counter Pain Medication Market

Published Date : Aug 2024

The global over the counter pain medication market has witnessed substantial growth over the past decade owing to rising incidence of health conditions such as arthritis, back pain, and other muscular skeletal disorders across the world. Easy availability of pain reli... View more

Coherent Market Insights India Active Pharmaceutical Ingredients Market

Published Date : Aug 2024

India has established itself as a global sourcing hub for generic APIs due to availability of large pool of scientifically skilled professionals and a robust manufacturing infrastructure. Lower costs of production and strong process chemistry skills have enabled India... View more

Coherent Market Insights Global Artificial Intelligence Ai In Pharmaceutical Market

Published Date : Jul 2024

Artificial intelligence (AI) has emerged as a transformative technology that is poised to revolutionize the pharmaceutical industry. By leveraging huge amounts of data and sophisticated algorithms, AI has the potential to help drug makers to accelerate drug discovery,... View more

Coherent Market Insights Global Analgesics Market

Published Date : Jul 2024

Global analgesics market growth is driven by rising prevalence of chronic and acute pain disorders worldwide. Analgesics drugs play a crucial role in relieving pain and enhancing the quality of life of patients. Changing lifestyles and higher stress levels have signif... View more

Coherent Market Insights Global Bronchitis Treatment Market

Published Date : Jul 2024

Bronchitis is an inflammation of the bronchi or air passages that carry air to the lungs. It causes coughing, wheezing and shortness of breath. Global bronchitis treatment market can witness growth due to rising rates of respiratory illnesses. Increasing pollution lev... View more

Coherent Market Insights Inflammatory Bowel Disease Market

Published Date : Jul 2024

Inflammatory bowel disease (IBD) refers to two conditions - Crohn's disease and ulcerative colitis - that are characterized by chronic inflammation within the gastrointestinal tract. IBD predominantly affects the small and large intestines but can sometimes extend thr... View more

Coherent Market Insights Cannabidiol Market

Published Date : Jul 2024

Cannabidiol or CBD is one of the primary cannabinoids found in cannabis plants like hemp and marijuana. It has several potential medical benefits and therapeutic effects without the psychotropic effects of THC, Delta-9-tetrahydrocannabinol. Rising awareness about the ... View more

Coherent Market Insights Primary Sclerosing Cholangitis Market

Published Date : Jul 2024

Primary sclerosing cholangitis (PSC) is a chronic progressive cholestatic liver disease characterized by multifocal strictures and fibrosis of the intrahepatic and extrahepatic bile ducts. It is associated with inflammatory bowel disease, usually ulcerative colitis, i... View more

Coherent Market Insights Glp 1 Receptor Agonist Market

Published Date : Jul 2024

GLP-1 receptor agonists are an important class of anti-diabetic drugs for the treatment of type 2 diabetes. These mimic the effects of endogenous glucagon-like peptide-1 (GLP-1), a peptide hormone released after eating which stimulates insulin secretion and suppresses... View more

Coherent Market Insights Genital Warts Treatment Market

Published Date : Jul 2024

Global genital warts treatment market growth is driven by rising prevalence of human papillomavirus (HPV) infections worldwide. Genital warts, also known as condyloma acuminata, are skin growths that appear in the genital and anal areas, and are caused by certain type... View more

Coherent Market Insights Life Sciences Bpo Market

Published Date : Jul 2024

The life sciences BPO market comprises outsourcing services provided to pharmaceutical, biotechnology, medical device companies and others in the healthcare industry. It helps life sciences companies to focus on core activities of drug discovery, product development a... View more

Coherent Market Insights Castrate Resistant Prostate Cancer Market

Published Date : Jul 2024

Global castrate resistant prostate cancer market growth is driven by rising prevalence of prostate cancer worldwide. Prostate cancer is one of the commonly occurring cancers among men. According to the data from American Cancer Society in 2020, around 191,930 new case... View more

Coherent Market Insights Gout Disease Treatment Market

Published Date : Jul 2024

Gout disease is a common form of inflammatory arthritis that occurs when uric acid crystals accumulate in the joints, typically in the big toe. It causes sudden and severe attacks of pain, swelling and tenderness in one or more joints. Rising consumption of alcohol, o... View more

Coherent Market Insights Antiseptic Market

Published Date : Jul 2024

The global antiseptic market has been witnessing significant growth in the recent years owing to the rising prevalence of infectious diseases such as hospital acquired infections. Increasing awareness about health and hygiene along with growing focus on preventive hea... View more

LogoCredibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.